Mark Maida, MD
NPI 1144378175 · Dermatology Physician · Los Alamitos, CA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Maida, MD is a Dermatology Physician provider in Los Alamitos, CA (NPI 1144378175).
Provider details
- NPI number
- 1144378175
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- A92335 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
7,690 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 3,610 | $8 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,074 | $98 |
| Destruction of Skin Growth, 1-14 Growths17110 | 865 | $128 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 636 | $44 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 | 353 | $187 |
| Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 74 | 52 |
| Ketoconazole | 33 | 26 |
| Metronidazole | 33 | 11 |
| Fluocinonide | 31 | 25 |
| Fluorouracil | 30 | 30 |
| Imiquimod | 29 | 23 |
| Clobetasol Propionate | 28 | 20 |
| Clindamycin Phosphate | 15 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,172 across 69 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-01-08
- Last updated
- 2020-07-14
- Certified
- 2020-07-14
Frequently asked questions
- What is Mark Maida's NPI number?
- Mark Maida's National Provider Identifier (NPI) is 1144378175, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Maida's specialty?
- Mark Maida is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Mark Maida located?
- Mark Maida's practice location on file with NPPES is 3772 Katella Ave, Los Alamitos, CA 90720-3104.
- What is Mark Maida's phone number?
- The practice phone number listed in the NPPES registry for Mark Maida is (562) 430-4294.
- Does Mark Maida accept Medicare?
- Mark Maida is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Maida's NPI active?
- Yes — Mark Maida's NPI (1144378175) is active in the NPPES registry as of the last update on 2020-07-14.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.